Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1

被引:42
|
作者
Huguenel, ED
Cohn, D
Dockum, DP
Greve, JM
Fournel, MA
Hammond, L
Irwin, R
Mahoney, J
McClelland, A
Muchmore, E
Ohlin, AC
Scuderi, P
机构
[1] NYU, LAB EXPT MED & SURG PRIMATES, MED CTR, TUXEDO PK, NY USA
[2] WHITE SANDS RES CTR, ALAMOGORDO, NM USA
[3] BAYER CORP, BERKELEY, CA USA
关键词
D O I
10.1164/ajrccm.155.4.9105055
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Intercellular adhesion molecule-1 (ICAM-1) is the cell surface receptor for the major class of human rhinoviruses, and tICAM(453), a truncated, soluble form of ICAM-1, has been shown previously to be a patent in vitro inhibitor of rhinovirus, in this report, we have investigated the in vivo efficacy of tICAM(453) for the prophylaxis of rhinovirus serotype 16 infection in the chimpanzee. Because chimpanzees do not show clinical symptoms of infection after rhinovirus challenge, infection was followed lay measuring antirhinovirus serum antibody responses and detection of virus shedding. By hath of these measures, intranasal application of tICAM(453) was efficacious in preventing rhinovirus infection in chimpanzees subsequently challenged with infectious doses of virus. These results suggest that the use of soluble rhinovirus receptor to inhibit virus binding to host cells should be feasible in humans.
引用
收藏
页码:1206 / 1210
页数:5
相关论文
共 50 条
  • [21] Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 are increased in women with ovarian hyperstimulation syndrome
    Daniel, Y
    Geva, E
    Amit, A
    Baram, A
    Englander, T
    Kupferminc, MJ
    Fait, G
    Lessing, JB
    FERTILITY AND STERILITY, 1999, 71 (05) : 896 - 901
  • [22] Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection - A randomized clinical trial
    Turner, RB
    Wecker, MT
    Pohl, G
    Witek, TJ
    McNally, E
    St George, R
    Winther, B
    Hayden, FG
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (19): : 1797 - 1804
  • [23] Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in liver disease, and their changes by treatment with interferon
    Marui, A
    Fukuda, Y
    Koyama, Y
    Nakano, I
    Urano, F
    Yamada, M
    Hayakawa, T
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1996, 24 (03) : 258 - 265
  • [24] Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in asymptomatic carriers of hepatitis C virus
    Fukuda, Y
    Nakano, I
    Katano, Y
    Marui, A
    Hayakawa, T
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1998, 26 (06) : 313 - 318
  • [25] Soluble Intercellular Adhesion Molecule-1 in children with Systemic Lupus Erythematosus
    Alyasins, S.
    Amin, R.
    ALLERGY, 2009, 64 : 257 - 257
  • [26] SOLUBLE INTERCELLULAR-ADHESION MOLECULE-1 IN A GEOGRAPHICAL CLUSTER OF SCLERODERMA
    PITTONI, V
    LITTA, A
    SQUILLONI, E
    BIFFERONI, E
    PRIORI, R
    VALESINI, G
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (12): : 1193 - 1194
  • [27] Stimulation of tumor growth by human soluble intercellular adhesion molecule-1
    Gho, YS
    Kim, PN
    Li, HC
    Elkin, M
    Kleinman, HK
    CANCER RESEARCH, 2001, 61 (10) : 4253 - 4257
  • [28] Prognostic impact of soluble intercellular adhesion molecule-1 in hepatocellular carcinoma
    Shimura, Tatsuo
    Shibata, Masahiko
    Gonda, Kenji
    Kofunato, Yasuhide
    Ishigame, Teruhide
    Okada, Ryo
    Sato, Naoya
    Kimura, Takashi
    Kenjo, Akira
    Marubashi, Shigeru
    ONCOLOGY LETTERS, 2018, 16 (05) : 6013 - 6018
  • [29] Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression
    Kondo, K
    Kitagawa, K
    Nagai, Y
    Yamagami, H
    Hashimoto, H
    Hougaku, H
    Hori, M
    ATHEROSCLEROSIS, 2005, 179 (01) : 155 - 160
  • [30] Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality?
    Becker, A
    van Hinsbergh, VWM
    Jager, A
    Kostense, PJ
    Dekker, JM
    Nijpels, G
    Heine, RJ
    Bouter, LM
    Stehouwer, CDA
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (01) : 1 - 8